Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey A Borgia

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Journal of Immunological Methods|March 25, 2014
Development of a bead-based immunoassay to routinely measure vimentin autoantibodies in the clinical settingCristina Fhied, Sivadasan Kanangat, Jeffrey A Borgia
The Annals of Thoracic Surgery|December 31, 2017
ReplyChristopher W Seder, Michael J Liptay, Jeffrey A Borgia
Journal of Neuroscience Methods|December 18, 2010
A novel approach for long-term oral drug administration in animal researchCassia R Overk, Jeffrey A Borgia, Elliott J Mufson
Annals of Translational Medicine|May 3, 2017
Practical and theoretical implications of weight gain in advanced non-small cell lung cancer patientsPhilip Bonomi, Marta Batus, Mary Jo Fidler, et al.
Molecular Cancer|July 20, 2013
Lyn, a Src family kinase, regulates activation of epidermal growth factor receptors in lung adenocarcinoma cellsParnetta Sutton, Jeffrey A Borgia, Philip Bonomi, et al.
Therapeutic Advances in Medical Oncology|March 17, 2012
Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfallsMary Jo Fidler, David D Shersher, Jeffrey A Borgia, et al.
Annals of Surgical Oncology|September 1, 2019
Prognostic Significance of Skeletal Muscle Loss During Early Postoperative Period in Elderly Patients with Esophageal CancerMary J Fidler, Jeffrey A Borgia, Philip D Bonomi, et al.
Current Eye Research|September 20, 2013
Quantitation of in vitro α-1 adrenergic receptor antagonist binding capacity to biologic melanin using tandem mass spectrometryJeffrey S Gaynes, Cedomir Micic, Bruce I Gaynes, et al.
Connective Tissue Research|December 15, 2012
Incomplete elongation of the chondroitin sulfate linkage region on aggrecan and response to interleukin-1βCasey Frankenberger, Jeffrey A Borgia, Praneeth D Edirisinghe, et al.
Oncotarget|May 17, 2018
Metabolic changes associated with metformin potentiates Bcl-2 inhibitor, Venetoclax, and CDK9 inhibitor, BAY1143572 and reduces viability of lymphoma cellsVineela Chukkapalli, Leo I Gordon, Parameswaran Venugopal, et al.
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Journal of Immunological Methods|March 25, 2014
Development of a bead-based immunoassay to routinely measure vimentin autoantibodies in the clinical settingCristina Fhied, Sivadasan Kanangat, Jeffrey A Borgia
The Annals of Thoracic Surgery|December 31, 2017
ReplyChristopher W Seder, Michael J Liptay, Jeffrey A Borgia
Journal of Neuroscience Methods|December 18, 2010
A novel approach for long-term oral drug administration in animal researchCassia R Overk, Jeffrey A Borgia, Elliott J Mufson
Annals of Translational Medicine|May 3, 2017
Practical and theoretical implications of weight gain in advanced non-small cell lung cancer patientsPhilip Bonomi, Marta Batus, Mary Jo Fidler, et al.
Molecular Cancer|July 20, 2013
Lyn, a Src family kinase, regulates activation of epidermal growth factor receptors in lung adenocarcinoma cellsParnetta Sutton, Jeffrey A Borgia, Philip Bonomi, et al.
Therapeutic Advances in Medical Oncology|March 17, 2012
Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfallsMary Jo Fidler, David D Shersher, Jeffrey A Borgia, et al.
Annals of Surgical Oncology|September 1, 2019
Prognostic Significance of Skeletal Muscle Loss During Early Postoperative Period in Elderly Patients with Esophageal CancerMary J Fidler, Jeffrey A Borgia, Philip D Bonomi, et al.
Current Eye Research|September 20, 2013
Quantitation of in vitro α-1 adrenergic receptor antagonist binding capacity to biologic melanin using tandem mass spectrometryJeffrey S Gaynes, Cedomir Micic, Bruce I Gaynes, et al.
Connective Tissue Research|December 15, 2012
Incomplete elongation of the chondroitin sulfate linkage region on aggrecan and response to interleukin-1βCasey Frankenberger, Jeffrey A Borgia, Praneeth D Edirisinghe, et al.
Oncotarget|May 17, 2018
Metabolic changes associated with metformin potentiates Bcl-2 inhibitor, Venetoclax, and CDK9 inhibitor, BAY1143572 and reduces viability of lymphoma cellsVineela Chukkapalli, Leo I Gordon, Parameswaran Venugopal, et al.
Pageof 8